Who Owns Anika Therapeutics Stock?
NASDAQ: ANIKHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 93.12%
- Institutions (% of float)
- 100.17%
- Held by insiders
- 7.04%
- Institutional holders
- 198
- Institutions 93.0%
- Insiders 7.0%
- Public and other 0.0%
Who owns Anika Therapeutics stock?
Institutional investors own about 93.1% of Anika Therapeutics's shares, spread across 198 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.04% of ANIK.
The largest institutional holders are Caligan Partners, LP (10.71%), Blackrock Inc. (10.53%) and Morgan Stanley (4.68%). Together, the top 10 institutions control 52.8% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their ANIK positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ANIK
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Caligan Partners, LP | 1.44M | 10.71% | 0.0% |
| Blackrock Inc. | 1.41M | 10.53% | -2.7% |
| Morgan Stanley | 626.37K | 4.68% | +2.0% |
| Acadian Asset Management. LLC | 606.54K | 4.53% | 0.0% |
| Vanguard Capital Management LLC | 565.91K | 4.22% | -1.1% |
| AQR Capital Management, LLC | 559.85K | 4.18% | +105.6% |
| Boothbay Fund Management, LLC | 529.64K | 3.95% | +0.0% |
| Dimensional Fund Advisors LP | 461.86K | 3.45% | +2.4% |
| Renaissance Technologies, LLC | 458.72K | 3.42% | -4.7% |
| Geode Capital Management, LLC | 419.17K | 3.13% | +26.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ANIK
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 397.82K | 2.97% |
| iShares Trust-iShares Russell 2000 ETF | 300.62K | 2.24% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 162.46K | 1.21% |
| College Retirement Equities Fd.-College Retirement Equities Fd. - Tota | 142.29K | 1.06% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 125.41K | 0.94% |
| Fidelity Covington Trust-Fidelity Small-Mid Multifactor ETF | 106.29K | 0.79% |
| iShares Trust-iShares Russell 2000 Value ETF | 105.40K | 0.79% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 86.70K | 0.65% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 66.25K | 0.49% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 65.79K | 0.49% |
Frequently asked questions
Who is the largest shareholder of Anika Therapeutics?
Caligan Partners, LP is the largest institutional shareholder of ANIK, owning 10.71% of shares outstanding (1.44M shares) as of its latest 13F filing.
What percentage of Anika Therapeutics is owned by institutions?
Institutions own about 93.1% of ANIK shares and 100.2% of the public float.
How much of Anika Therapeutics do insiders own?
Insiders, such as officers and directors, own about 7.04% of ANIK shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.